India's most comprehensive portal on pharmaceutical News, Tenders, Patents, Notifications, Projects, Stocks, Drugs & Medicines

Bristol-Myers updates result from CheckMate -915 phase 3 study of Opdivo plus Yervoy versus Opdivo alone in patients with resected high-risk melanoma and PD-L1 <1%

Join Pharma | Login

	Editorial


	CARe Keralam, Dying a Premature Death?
	Wednesday, November 20, 2019
	Recently, there were reports that the CARe Keralam cluster project, formed to support medicinal plant cultivators and to promote classical Ayurveda drugs by conducting scientific validation studies, is on the verge of closure.
	Past Editorial...

TODAY'S NEWS


18:00 [IST]	Bristol-Myers updates result from CheckMate -915 phase 3 study of Opdivo plus Yervoy versus Opdivo alone in patients with resected high-risk melanoma and PD-L1 <1%
17:45 [IST]	Pratigya Campaign study reveals medical abortion drugs rapidly vanishing from chemists shops
17:10 [IST]	PerkinElmer sets up advanced in vivo imaging facility at IISER Pune
17:00 [IST]	Researchers identify promising drug combination against lethal childhood brain cancers
16:45 [IST]	GOQii launches Vital ECG to monitor heart health
16:00 [IST]	Sierra Oncology initiates MOMENTUM phase 3 trial of momelotinib to treat myelofibrosis

more news >>

TOP NEWS


08:00 [IST]	Indian excipient industry to approach DCGI to curb irrational usage of excipients in domestic market
08:00 [IST]	Compliance is the main mantra for regulators: Maharashtra FDA Commissioner
08:00 [IST]	India gearing up for SMART immunologics to facilitate cancer management through collaborations
08:00 [IST]	TN Pharmacist Munnetra Sangham to send representatives from all districts to Jantar Mantar for agitation on Nov 29
08:00 [IST]	ARTIST presses for scale up of innovations for nutrition and lifestyle to address health problems at source level
08:00 [IST]	Pharma cos to start operations at MIHAN bulk drugs park in Nagpur soon following land allocation

more news >>

YESTERDAY'S NEWS


18:00 [IST]	CStone begins phase I bridging registrational study of ivosidenib in China
17:00 [IST]	Umbilical cord milking may be linked to higher risk of brain bleeding in preterm infants: Study
16:30 [IST]	UNHIE, BIRAC and Social Alpha announce India accelerator platform for healthcare innovations
16:00 [IST]	CNS Pharma acquires worldwide rights for brain cancer drug, Berubicin from Houston Pharma
15:50 [IST]	Roche launches DCGI approved atezolizumab in India to treat extensive-stage SCLC
15:30 [IST]	Zydus gets US FDA marketing nod for generic Isordil tablet & Desonide cream

more news >>

INTERVIEW


MSMEs contribution to Indian pharma significant
Sunil Attavar, president of Karnataka Drugs and Pharmaceutical Manufacturers’ Association and managing director, Group Pharma

Past Interviews...

	What's New?

NPPA notification dated November 14, 2019 fixing retail prices of 12 formulations under Drugs (Prices Control) Order, 2013 in relating to 70th Authority meeting dated 30.10.2019 NPPA Notification dated November 08, 2019 fixing/revising retail prices of 14 formulation under Drugs (Prices Control) Order, 2013 in relating to 70th Authority meeting dated 30.10.2019 NPPA Notification dated November 08, 2019 fixing retail prices of 59 formulations under Drugs (Prices Control) Order, 2013 in relating to 70th Authority meeting dated 30.10.2019 NPPA Notification dated November 08, 2019 fixing/revising ceiling prices of 1 another formulation under Drugs (Prices Control) Order, 2013 in relating to 70th Authority meeting dated 30.10.2019 NPPA Notification dated November 08, 2019 fixing/revising ceiling prices of 1 formulation under Drugs (Prices Control) Order, 2013 in relating to 70th Authority meeting dated 30.10.2019

Opinion Poll

Is the DoP's recent amendment to Para 32 of DPCO to provide 5-year price control exemption to patented innovative & rare diseases drugs a right move to increase accessibility ?

YesNoCan't Say

View Past Poll

Corporate

	Pharma Stocks
	Executive Diary
	Pharma People
	Product Launches

Special Features

Features

Chronicle Pharmabiz Specials

		Forthcoming

		Past

Forthcoming Events

		International

		Domestic

TENDERS & PROJECTS

	Tenders & Enquiries
	Pharma Projects

CORPORATE

	Company Profile
	Corporate Results
	Corporate X-ray
	Pharmabiz Studies of Top Companies

US FDA UPDATE

	US FDA: ANDA
	US FDA: Warnings
	US FDA: Approved NMEs
	US FDA: New Approvals

EXPORT & IMPORT

	Drug Export Procedures
	Drug Units With WHO GMP Certification
	Pharma Export Data
	Import Reg. Update

PHARMA LAWS & DOCUMENTS

	Notifications
	Pharma Regulations
	Patent Laws and Amendments
	Patent Scan
	Documents
	New Drug Approvals
	Notified Prices

LIST OF LABS & GOVT. BODIES

	Govt Recognised In-House R&D Units
	AICTE Boards & Committees
	List of Indian CROs
	List of CROs (International)
	Govt & approved labs of India
	List of State Drugs Controllers